AUA 2018 Prostate Cancer - Results from #100

Viewing 101-109 of 109 articles

AUA 2018: Assessing the Under-Estimation of Nodal Tumour Burden by 68ga-PSMA and 11c-Choline PET/CT Scan in Patients Treated with Salvage Lymph Node Dissection for Nodal Recurrence of Prostate Cancer

AUA 2018: Phase 3 Study of Intermittent Monotherapy Versus Continuous Combined Androgen Deprivation

AUA 2018: Results from SPARTAN: PSA Outcomes in Patients with Nonmetastatic Castration-Resistant Prostate Cancer Treated with Apalutamide

AUA 2018: The PROSPER Trial: Chemotherapy-related Endpoints in Patients with Nonmetastatic Castration-resistant Prostate Cancer Treated with Enzalutamide

AUA 2018: Crossfire Debate: Controversies in Prostate Cancer (Con) – ADT plus Abiraterone is Key to Prolonging Survival in Oligometastatic Prostate Cancer

AUA 2018: A Crossfire Debate: Controversies in Prostate Cancer (Pro) – Focal Ablation of Oligometastatic Prostate Cancer

AUA 2018: Duration of PSA Surveillance after Radical Prostatectomy: A Risk Adapted Approach

AUA 2018: Should Gleason Score at the Positive Surgical Margin appear on the Pathology Report for Robot-Assisted Radical Prostatectomy?

AUA 2018: Establishment of the Optimal Follow-Up Schedule After Radical Prostatectomy

1
2
3
4
5
6